Funder: Breakthrough T1D

Due Dates (Anticipated): June 2026 (Full application via RMS360, projected)

Funding Amounts: Up to $200,000/year (including max 10% indirects), for up to 5 years; not generally renewable after 5 years.

Summary: Supports early-career clinical investigators in patient-oriented type 1 diabetes research as they transition to independence, emphasizing innovative and impactful studies.

Key Information: Applications in long-term complications are not accepted; psychosocial and behavioral health projects are eligible.